[Contact dermatitis caused by pristinamycin after sensitization to topical virginiamycin].
Pillette
M
M
Service de Dermatologie, Tours.
Claudel
J P
JP
Muller
C
C
Lorette
G
G
D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000276:immunology; D003429:Cross Reactions; D003875:Drug Eruptions / Q000209:etiology*; D004485:Eczema / Q000139:chemically induced; D005148:Facial Dermatoses / Q000139:chemically induced; D006801:Humans; D008297:Male; D008875:Middle Aged; D009824:Ointments; D010456:Peptides, Cyclic / Q000009:adverse effects / Q000276:immunology; D014769:Virginiamycin / Q000009:adverse effects* / Q000276:immunology
D000900:Anti-Bacterial Agents; D009824:Ointments; D010456:Peptides, Cyclic; D014769:Virginiamycin
Toxidermie à la pristinamycine après sensibilisation à la virginiamycine topique.